Seminar 879


Biological Products Quality Inspection Report: 2016-2017

Cheng-chu Hsieh



In 1988, we established a pharmaceutical factory at the Animal Health Research Institute (AHRI) that complied with the GMP standard requirements. The main tasks of the biological products division are the production, development, storage and supply of vaccines and diagnostic reagents. AHRI currently possesses 21 manufacturing licenses for various biological animal products including a Newcastle disease hemaggluutination antigen, frozen-dried lapinized hog cholera seed virus, a pullorum disease antigen, a frozen-dried lapinized hog cholera vaccine, a swine pseudorabies inactivated vaccine, a bovine ephemeral fever inactivated vaccine, a waterfowl parvovirus live vaccine, a goat pox attenuated live vaccine, a grouper iridovirus inactivated vaccine, and RA inactivated trivalent bacterins (serotpye 1, 2 and 6), among many others. An analysis of data from 2016-2017 shows that more than 20 different batches of biological preparations are manufactured each year, providing for domestic epidemic prevention and diagnosis. To further improve the quality of biological animal products manufactured in Taiwan and their international competitiveness, we must continue to promote the implementation of process validation processes in pharmaceutical factories that conform to current Good Manufacture Practice (cGMP).


Report on the Attendance of the XXth World Veterinary Poultry Association Congress in the United Kingdom


Yu-Pin Liu



The World Veterinary Poultry Association (WVPA) Congress is an important international veterinary congress held every two years. The XXth WVPA Congress took place in Edinburgh, Scotland from September 4-8, 2017, and the delegate numbers of poultry research scientists were in excess of 1200 and included participants from over 70 countries. The congress events included scientific presentations, clinical case reports, and posters. In this Congress, we presented a poster entitled “H5 clade highly pathogenic avian influenza viruses and generation of novel reassortants, Taiwan, 2015-2016”. Through our presentation and attendance at the congress, we were able to share our research results on avian influenza and thereby enhance the visibility of bird flu research in Taiwan. Furthermore, we were able to learn about the latest poultry disease research topics, novel diagnostic techniques, and the prevalence of poultry diseases around the world. We therefore hope that this congress will further enhance our expertise, improve the competency of personnel in our laboratory, and strengthen our diagnostic technologies.